September 12, 2024

Update on commercialisation of PromarkerD in the USA

June 17, 2024

Appointment of medical device sales agency in EU

March 18, 2024

Update on commercialisation of PromarkerD in the USA and commercial development of the Promarker diagnostics pipeline

December 20, 2023

PromarkerD to be available in Chile in expanded deal with Omics Global Solutions

November 22, 2023

US Medicare confirms reimbursement price for PromarkerD

September 29, 2023

PromarkerD US CMS price & TGA decision

May 10, 2023

Proteomics International & Sonic Healthcare USA sign exclusive licence agreement

May 3, 2023

PromarkerD test scores show treatment with canagliflozin can lessen risk of diabetic kidney disease

April 26, 2023

Clinical Advisory Board expanded to support PromarkerD USA and global rollout

February 15, 2023

Distribution agreement for PromarkerD in Britain extended

January 3, 2023

CPT PLA Reimbursement Code Approved in US for PromarkerD

March 28, 2024

Investor Presentation

February 6, 2024

Investor presentation – Euroz Hartleys Healthcare Forum

January 25, 2024

Investor Presentation

November 23, 2023

Chairman’s Address and Investor Presentation

November 16, 2023

Bell Potter Healthcare Conference

October 30, 2023

Investor Presentation – Non-deal Roadshow

September 4, 2023

Experts in Type 2 Diabetes and Chronic Kidney Disease at the Australasian Diabetes Congress conference discuss how our PromarkerD test can help people with Type 2 Diabetes preserve their kidney health

September 4, 2023

Experts in Type 2 Diabetes and Chronic Kidney Disease at the Australasian Diabetes Congress conference discuss how our PromarkerD test can help people with Type 2 Diabetes preserve their kidney health

July 25, 2023

Bioshares Biotech Summit

May 18, 2023

Video Interview – Exclusive agreement with Sonic Healthcare USA

February 2, 2023

Investor Presentation Euroz Hartleys Healthcare Forum

Scroll to Top